Literature DB >> 34258646

[Ampullary neoplasms: surgical management].

Martin Schneider1, Markus W Büchler2.   

Abstract

BACKGROUND: Endoscopically unresectable adenomas and carcinomas of the greater duodenal papilla and ampulla of the bile duct necessitate surgical resection. The surgical techniques need to be adapted to local tumor expansion and patterns of infiltrative growth.
OBJECTIVE: Based on the current scientific data and developments this article provides an overview of indications for surgical resection, surgical strategies and dissection techniques for ampullary tumors.
MATERIAL AND METHODS: A review of the literature addressing surgical management of ampullary neoplasms was performed. Current evidence and recommendations were summarized. RESULTS AND
CONCLUSION: Ampullary neoplasms can originate from intestinal or pancreatobiliary epithelial cells. Differentiating these histopathological subtypes is of crucial relevance concerning therapeutic strategy and prognosis in ampullary adenocarcinoma. All ampullary adenomas carry a risk of malignant transformation and therefore justify resection. Endoscopic papillectomy, surgical transduodenal ampullectomy and partial pancreatoduodenectomy are suitable resection techniques for ampullary adenoma. The selection of the procedure depends on intraductal tumor extension, tumor size and degree of dysplasia. Ampullary carcinoma is managed by upfront pancreatoduodenectomy comprising systematic lymph node dissection and level II dissection of the mesopancreas. Lymph node status and perineural sheath invasion are key prognostic factors concerning overall survival.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Ampullary adenoma; Ampullary carcinoma; Papillectomy; Partial pancreatoduodenectomy; Transduodenal ampullectomy

Mesh:

Year:  2021        PMID: 34258646     DOI: 10.1007/s00104-021-01457-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  2 in total

1.  Technical advances in surgery for pancreatic cancer.

Authors:  M Schneider; T Hackert; O Strobel; M W Büchler
Journal:  Br J Surg       Date:  2021-07-23       Impact factor: 6.939

2.  Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort study.

Authors:  Stijn van Roessel; Eline C Soer; Lois A Daamen; Demi van Dalen; Arantza Fariña Sarasqueta; Martijn W J Stommel; I Quintus Molenaar; Hjalmar C van Santvoort; Vincent C J van de Vlasakker; Ignace H J T de Hingh; Jesse V Groen; J Sven D Mieog; Jacob L van Dam; Casper H J van Eijck; Geertjan van Tienhoven; Heinz-Josef Klümpen; Johanna W Wilmink; Olivier R Busch; Lodewijk A A Brosens; Bas Groot Koerkamp; Joanne Verheij; Marc G Besselink
Journal:  Eur J Surg Oncol       Date:  2021-03-15       Impact factor: 4.424

  2 in total
  1 in total

1.  Our Experience With Transduodenal Surgical Ampullectomy.

Authors:  Samer Dbouk; Nagham Bazzi; Lea Daou; Zaynab Shaalan; Ali Choukr
Journal:  Cureus       Date:  2022-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.